RPS Advisory Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
1,002
-1
-0.1% -$1.02K 0.79% 22
2026
Q1
$922K Sell
1,003
-48
-5% -$48.7K 0.52% 26
2025
Q4
$1.13M Sell
1,051
-126
-11% -$120K 0.53% 36
2025
Q3
$898K Buy
1,177
+16
+1% +$11.9K 0.44% 40
2025
Q2
$905K Buy
1,161
+141
+14% +$110K 0.5% 32
2025
Q1
$842K Buy
1,020
+57
+6% +$47.4K 0.6% 18
2024
Q4
$744K Sell
963
-35
-4% -$29K 0.46% 43
2024
Q3
$884K Sell
998
-37
-4% -$33.3K 0.63% 32
2024
Q2
$937K Buy
+1,035
New +$828K 0.86% 29

Other funds holding LLY

RPS Advisory Solutions's LLY Position: Q2 2026 in Review

RPS Advisory Solutions reduced its Eli Lilly (LLY) stake by 0.1% in Q2 2026, selling an estimated $1.02K and leaving 1,002 shares worth $1.2M. The position accounts for 0.79% of the portfolio, ranked #22.

RPS Advisory Solutions first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • RPS Advisory Solutions held 1,002 shares of Eli Lilly worth $1.2M as of Q2 2026.
  • RPS Advisory Solutions sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.79% of RPS Advisory Solutions's portfolio in Q2 2026, its #22 holding.
  • RPS Advisory Solutions first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on RPS Advisory Solutions's 13F filing for Q2 2026, filed 11 Aug 2026.